InvestorsHub Logo
Followers 53
Posts 1823
Boards Moderated 0
Alias Born 03/22/2015

Re: jour_trader post# 308981

Thursday, 02/07/2019 3:40:49 PM

Thursday, February 07, 2019 3:40:49 PM

Post# of 410103
What are you talking about?




I think so too, but am less positive on the outcome of the trial. All other calcium blockers have failed.







No other calcium channels have had safety & efficacy testing, so I'm not sure what this even means. But even if they had, I have previously extensively posted on why isradipine was chosen for these tests over all other calcium channel blockers (highest relative affinity for CaV1.3 receptors in the brain relative CaV1.2 receptors in the peripheral circulatory system). I would very much expect every other calcium channel to fail, and it wouldn't have any predictive value in regards to isradipine's success.






Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News